A Phase I, Single Center, Placebo-Controlled, Blinded Pilot Study of Ipratropium Bromide in Children Admitted to the Intensive Care Unit With Status Asthmaticus

Trial Profile

A Phase I, Single Center, Placebo-Controlled, Blinded Pilot Study of Ipratropium Bromide in Children Admitted to the Intensive Care Unit With Status Asthmaticus

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Ipratropium bromide (Primary) ; Corticosteroid; Salbutamol
  • Indications Status asthmaticus
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
    • 24 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
    • 01 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top